Zoetis Inc. (ZTS) Presents at BofA Securities Animal Health Summit Transcript
Zoetis Inc. (ZTS) Presents at BofA Securities Animal Health Summit Transcript
Alliance Wealth Advisors LLC UT Lowers Stock Position in Zoetis Inc. $ZTS
Alliance Wealth Advisors LLC UT trimmed its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 21.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,188 shares of the company's stock after selling 4,430 shares during the
Why Zoetis (ZTS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates
ZTS stock rises after Q4 earnings and revenues top estimates, as strong international growth and upbeat 2026 guidance offset U.S. softness.
Zoetis (ZTS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Zoetis (ZTS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zoetis (ZTS) Beats Q4 Earnings and Revenue Estimates
Zoetis (ZTS) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $1.4 per share a year ago.
Zoetis Gears Up to Report Q4 Earnings: Here's What to Expect
ZTS is set up for Q4 earnings beat, fueled by strong international companion animal products sales, even as weaker U.S. demand weighs on results.
Curious about Zoetis (ZTS) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of Zoetis (ZTS) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Zoetis (ZTS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Zoetis (ZTS) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
